Jura Bio
Using the full potential of gene editing, JURA Bio is creating a novel therapeutic platform of cell-based therapies against autoimmune diseases that are both curative and definitive. We have developed a disruptive treatment approach that is harnessing the body's immune system to neutralize pathologic cells. We are developing therapeutic cells engineered to bind to and kill pathologic immune cells.
Last updated on
About Jura Bio
Founded
2017Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$16MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
WorcesterState
MassachusettsCountry
United StatesJura Bio
Find your buyer within Jura Bio